Cosmos Health CCO resigns; shareholders approve reverse split authorization and equity plan

Cosmos Health Inc.

Chief Communications Officer Pavlos Ignatiades resigned effective Sept 20, 2023.
Shareholders elected all six director nominees with over 94% affirmative votes each.
Ratified October 2022 public offering (97.77% for) and approved 2023 equity incentive plan (94.19% for).
Board authorized to effect reverse stock split at its discretion; 97.67% of votes in favor.

item 5.02 item 5.07

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Pavlos Ignatiades

Chief Communications Officer

COSM · Cosmos Health Inc.

Effective: 2023-09-20
Filed: September 22, 2023, 7:59 PM ET

On September 20, 2023, Pavlos Ignatiades, our Chief Communications Officer, resigned effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Pavlos Ignatiades resigned as Chief Communications Officer at Cosmos Health Inc..

Action: resigned
Role: Chief Communications Officer

Exact text from the filing

On September 20, 2023, Pavlos Ignatiades, our Chief Communications Officer, resigned effective immediately.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cosmos Health Inc. shareholders approved To ratify the October 2022 Public Offering at the 2023-09-18 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-09-18

Exact text from the filing

2. To ratify the October 2022 Public Offering: For Against Abstain % Votes Affirmative 4,770,999 106,633 2,070 97.77 %

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cosmos Health Inc. shareholders approved To authorize the Board of Directors to amend the Articles of Incorporation to effect a reverse stock split of the Company's outstanding common stock at their discretion at the 2023-09-18 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2023-09-18

Exact text from the filing

4. To authorize the Board of Directors to amend the Articles of Incorporation to effect a reverse stock split of the Company’s outstanding common stock at their discretion: For Against Abstain % Votes Affirmative 4,766,157 113,059 486 97.67 %

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cosmos Health Inc. shareholders approved Election of Directors at the 2023-09-18 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-09-18

Exact text from the filing

1. Election of Directors: Nomination For Withheld % Votes Affirmative 01 - Grigorios Siokas 4,606,832 272,870 94.41 % 02 - Demetrios G. Demetriades 4,867,713 11,989 99.75 % 03 - John J. Hoidas 4,872,529 7,173 99.85 % 04 - Dr. Anastasios Aslidis 4,808,836 70,866 98.55 % 05 - Dr. Manfred Ziegler 4,829,695 50,007 98.98 % 06 - Suhel Bhutawala 4,829,523 50,179 98.97 %

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cosmos Health Inc. shareholders approved To approve the Company's 2023 equity incentive plan at the 2023-09-18 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-09-18

Exact text from the filing

3. To approve the Company’s 2023 equity incentive plan: For Against Abstain % Votes Affirmative 4,596,072 277,077 6,553 94.19 %

View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Cosmos Health Inc. filing history →

Source: SEC EDGAR

accession 0001477932-23-007031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.